163 related articles for article (PubMed ID: 11938460)
1. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
[TBL] [Abstract][Full Text] [Related]
2. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
[TBL] [Abstract][Full Text] [Related]
3. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
Eliopoulos N; Bovenzi V; Le NL; Momparler LF; Greenbaum M; Létourneau S; Cournoyer D; Momparler RL
Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
[TBL] [Abstract][Full Text] [Related]
5. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
6. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
[TBL] [Abstract][Full Text] [Related]
7. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
[TBL] [Abstract][Full Text] [Related]
8. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
[TBL] [Abstract][Full Text] [Related]
11. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.
Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K
J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639
[TBL] [Abstract][Full Text] [Related]
12. Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro.
Schwarz EJ; Reger RL; Alexander GM; Class R; Azizi SA; Prockop DJ
Gene Ther; 2001 Aug; 8(16):1214-23. PubMed ID: 11509954
[TBL] [Abstract][Full Text] [Related]
13. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
Eliopoulos N; Lejeune L; Martineau D; Galipeau J
Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
[TBL] [Abstract][Full Text] [Related]
14. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors.
Kume A; Hashiyama M; Suda T; Ozawa K
Stem Cells; 1999; 17(4):226-32. PubMed ID: 10437986
[TBL] [Abstract][Full Text] [Related]
15. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells.
Marx JC; Allay JA; Persons DA; Nooner SA; Hargrove PW; Kelly PF; Vanin EF; Horwitz EM
Hum Gene Ther; 1999 May; 10(7):1163-73. PubMed ID: 10340548
[TBL] [Abstract][Full Text] [Related]
17. Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
Deng W; Bivalacqua TJ; Chattergoon NN; Jeter JR; Kadowitz PJ
Stem Cells; 2004; 22(7):1279-91. PubMed ID: 15579646
[TBL] [Abstract][Full Text] [Related]
18. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
20. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
